Mechanism of Action - Jakavi
Uncontrolled JAK/STAT signalling is characteristic of both polycythaemia vera (PV) 1–5 and for myelofibrosis (MF). 6
JAKs are tyrosine kinases that transmit signals from cytokine or growth factor receptors to the cell...- Twitter Linkedin Facebook Pinterest Google plus
Dose recommendation - Jakavi
Patient Resources - Jakavi
Indications - Jakavi
Myelofibrosis (MF) Jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera...
Twitter Linkedin Facebook Pinterest Google plusEfficacy
Indication
Safety Profile
Reimbursement
Dosing
Xolair®: Refund first claim (A) (French)
Download French document To receive by post, click on the "Add to card" button below